Quality of life and the outcome of established rheumatoid arthritis

Best Practice and Research: Clinical Rheumatology

Volumn 25, Issue 4, 2011, Pages 585-606

  Kingsley, Gabrielle ^a   Scott, Ian C ^b   Scott, David L ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Clinical outcomes; Patient related outcome measures (PROMS); Quality adjusted life years (QALYs); Quality of life; Rheumatoid arthritis

Indexed keywords

ABATACEPT; CERTOLIZUMAB PEGOL; DISEASE MODIFYING ANTIRHEUMATIC DRUG; INFLIXIMAB; PEGSUNERCEPT; RITUXIMAB; SALAZOSULFAPYRIDINE;

ADL DISABILITY; ARTICLE; CLINICAL ASSESSMENT; COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; DISEASE DURATION; HEALTH ASSESSMENT QUESTIONNAIRE; HEALTH CARE COST; HUMAN; JOINT INJURY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RHEUMATOID ARTHRITIS; SHORT FORM 36; SYNOVITIS; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 82955227648     PISSN: 15216942     EISSN: 15321770     Source Type: Journal    
DOI: 10.1016/j.berh.2011.10.003     Document Type: Review

References (95)

1. S. Marshall, K. Haywood, and R. Fitzpatrick Impact of patient-reported outcome measures on routine practice: a structured review Journal of Evaluation in Clinical Practice 12 2006 559 568 (Pubitemid 44427288)
2. J. La Puma, and E.F. Lawlor Quality-adjusted life-years. Ethical implications for physicians and policymakers Journal of the American Medical Association 263 1990 2917 2921
3. L. Linde, J. Sørensen, M. Ostergaard, K. Hørslev-Petersen, and M.L. Hetland Health-related quality of life: validity, reliability, and responsiveness of SF-36, 15D, EQ-5D, RAQoL, and HAQ in patients with rheumatoid arthritis Journal of Rheumatology 35 2008 1528 1537
4. A.A. Küükdeveci, A. Tennant, G. Grimby, and F. Franchignoni Strategies for assessment and outcome measurement in physical and rehabilitation medicine: an educational review Journal of Rehabillitation on Medicine 43 2011 661 672
5. J.E. Heller, and N.A. Shadick Outcomes in rheumatoid arthritis: incorporating the patient perspective Current Opinion Rheumatology 19 2 2007 Mar 101 105 (Pubitemid 46208765)
6. S. Nikolaus, and M.A. van de Laar Quality of Life: measuring fatigue in rheumatoid arthritis Nature Reviews of Rheumatology 7 2011 562 564
7. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/ PublicationsPolicyAndGuidance/DH-117353.
8. Transparency in outcomes - a framework for the NHS, http://www.dh.gov.uk/ en/Consultations/Liveconsultations/DH-117583.
9. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/ PublicationsPolicyAndGuidance/DH-122944.
10. J.E. Ware, and C.D. Sherbourne The MOS 36-Item short-form health survey (SF-36). I. Conceptual framework and item selection Medical Care 30 1992 473 483
11. T.K. Kvien, S. Kaasa, and L.M. Smedstad Performance of the Norwegian SF-36 Healthy Survey in patients with rheumatoid arthritis. II. A comparison of the SF-36 with disease-specific measures Journal of Clinical Epidemiology 51 1998 1077 1086 (Pubitemid 28527163)
12. R. Rabin, and F. de Charro EQ-5D: a measure of health status from the EuroQol Group Annals of Medicine 33 2001 337 343 (Pubitemid 32675374)
13. J.F. Fries, P.W. Spitz, and D.Y. Young The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales Journal of Rheumatology 9 1982 789 793
14. B.B. Mittleman, and P.E. Lipsky Patient-centered outcomes: a bridge too far? Nature Clinical Practice Rheumatology 2 2006 457 (Pubitemid 44340416)
15. A. Aggarwal, S. Chandran, and R. Misra Physical, psychosocial and economic impact of rheumatoid arthritis: a pilot study of patients seen at a tertiary care referral centre The National Medical Journal of India 19 2006 187 191 (Pubitemid 44596405)
16. G.H. Alishiri, N. Bayat, A.F. Ashtiani, S.A. Tavallaii, S. Assari, and Y. Moharamzad Logistic regression models for predicting physical and mental health-related quality of life in rheumatoid arthritis patients Modern Rheumatology 18 2008 601 608
17. S.J. Bartlett, R. Piedmont, A. Bilderback, A.K. Matsumoto, and J.M. Bathon Spirituality, well-being, and quality of life in People with rheumatoid arthritis Arthritis Rheumatism 49 2003 778 783 (Pubitemid 37523629)
18. G.C. Chermont, S.C. Kowalski, R.M. Ciconelli, and M.B. Ferraz Resource utilization and the cost of rheumatoid arthritis in Brazil Clinical and Experimental of Rheumatology 26 2008 24 31 (Pubitemid 351385252)
19. J. Dadoniene, T. Uhlig, S. Stropuviene, A. Venalis, A. Boonen, and T.K. Kvien Disease activity and health status in rheumatoid arthritis: a case-control comparison between Norway and Lithuania Annals of the Rheumatic Diseases 62 2003 231 235 (Pubitemid 36238086)
20. G.A. Geuskens, A. Burdorf, A.W.M. Evers, and J.M.W. Hazes Clear associations between demographic and psychosocial factors and health-related quality of life in patients with early inflammatory joint Complaints Journal of Rheumatology 35 2008 1754 1761
21. M.S. Heiberg, B.Y. Nordvag, K. Mikkelsen, E. Rodevand, C. Kaufman, and P. Mowinckel The comparative effectiveness of tumor necrosis factor-Blocking agents in patients with rheumatoid arthritis and patients with Ankylosing Spondylitis Arthritis and Rheumatism 52 2005 2506 2512 (Pubitemid 41117438)
22. H.M. Lapsley, L.M. March, K.L. Tribe, M.J. Cross, B.G. Courtenay, and P.M. Brooks Living with rheumatoid arthritis: expenditures, health status, and social impact on patients Annals of the Rheumatic Diseases 61 2002 818 821
23. L. Linde, J. Sorensen, M. Ostergaard, Horslev-Petersen, and M.L. Hetland Health-Related quality of life: validity, reliability, and responsiveness of SF-36, EQ-15D, EQ-5D, RAQoL, and HAQ in patients with rheumatoid arthritis Journal of Rheumatology 35 2008 1528 1537
24. H.S.J. Picavet, and N. Hoeymans Health related quality of life in multiple musculoskeletal diseases: SF-36 and EQ-5D in the DMC3 study Annals of the Rheumatic Diseases 63 2004 723 729 (Pubitemid 38658404)
25. I. Rupp, H.C. Boshuizen, C.E. Jacobi, H.J. Dinant, and G.A.M. Van Den Bos Comorbidity in patients with rheumatoid arthritis: effect on health-related quality of life Journal of Rheumatology 31 2004 58 65 (Pubitemid 38067522)
26. F. Salaffi, A. Stancati, R. Neri, W. Grassi, and S. Bombardieri Measuring functional disability in early rheumatoid arthritis: the validity, reliability and responsiveness of the Recent-Onset Arthritis Disability (ROAD) index Clinical and Experimental Rheumatology 23 2005 S31 S42 (Pubitemid 46657509)
27. D.A. Ruta, N.P. Hurst, P. Kind, M. Hunter, and A. Stubbings Measuring health status in British patients with rheumatoid arthritis: reliability, validity and responsiveness of the short form 36-Item health survey (SF-36) British Journal of Rheumatology 37 1998 425 436
28. F. Salaffi, A. Stancati, and M. Carotti Responsiveness of health status measures and utility-based methods in patients with rheumatoid arthritis Clinical Rheumatology 21 2002 478 487 (Pubitemid 36054445)
29. I. Thyberg, T. Skogh, U.A.M. Hass, and B. Gerdle Recent-Onset rheumatoid arthritis: a 1-Year observational study of correlations between health-related quality of life and Clinical/Laboratory data Journal of Rehabillitation on Medicine 37 2005 159 165 (Pubitemid 40775155)
30. M.K. Soderlin, Y. Lindroth, and L.T.H. Jacobsson Trends in medication and health-related quality of life in a population-based rheumatoid arthritis register in Malmo, Sweden Rheumatology 46 2007 1355 1358 (Pubitemid 47244513)
31. P. Emery, M. Kosinski, T. Li, M. Martin, G.R. Williams, and J.C. Becker Treatment of rheumatoid arthritis patients with abatacept and methotrexate significantly improved health-related quality of life Journal of Rheumatology 33 2006 681 689
32. D.E. Furst, R. Fleischmann, E. Kopp, M. Schiff, C. Edwards 3rd, and A. Solinger A phase 2 dose-finding study of PEGylated recombinant methionyl human soluble tumor necrosis factor type I in patients with rheumatoid arthritis Journal of Rheumatology 32 2005 2303 2310 (Pubitemid 41780638)
33. E. Keystone, G.R. Burmester, R. Fjurie, J.E. Lovless, P. Emery, and J. Kremer Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis Refractory to anti-tumor necrosis factor therapy Arthritis Rheumatism 59 2008 785 793 (Pubitemid 351847560)
34. P.J. Mease, D.A. Revicki, J. Szechinski, M. Greenwald, A. Kivitz, and L. Barile-Fabris Improved health-related quality of life for patients with active rheumatoid arthritis receiving rituximab- results of the dose-ranging assessment: international clinical evaluation of rituximab in rheumatoid arthritis (DANCER) trial Journal of Rheumatology 35 2008 20 30
35. M. Schiff, M. Keiserman, C. Codding, S. Songcharoen, A. Berman, and S. Nayiager Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate Annals of the Rheumatic Diseases 67 2008 1096 1103
36. R. Westhovens, J.C. Cole, T. Li, M. Martin, R. Maclean, and P. Lin Improved health-related quality of life for rheumatoid arthritis patients treated with abatacept who have inadequate response to anti-TNF therapy in a double-blind, placebo-controlled, multicentre randomized clinical trial Rheumatology 45 2006 1238 1246 (Pubitemid 44542064)
37. H. Lempp, F. Ibrahim, T. Shaw, D. Hofmann, H. Graves, and G. Thornicroft Comparative quality of life in patients with depression and rheumatoid arthritis International Review of Psychiatry 23 2011 118 124
38. A. Bowling, M. Bond, C. Jenkinson, and D.L. Lamping Short form 36 (SF-36) health survey questionnaire: which normative data should be used? Comparisons between the norms provided by the Omnibus survey in Britain, the health survey for England and the Oxford healthy life survey Journal of Public Health Medicine 21 1999 255 270 (Pubitemid 29446064)
39. J.E. Ware, K.K. Snow, and M. Kosinski SF-36 health survey: Manual and Interpretation Guide 1993 QualityMetric Incorporated Lincoln, RI 2000
40. J.H. Loge, and S. Kaasa Short Form 36 (SF-36) health survey: normative data from the general Norweigian population Scandinavian Journal of Public Health 26 1998 250 258 (Pubitemid 128671032)
41. F. Creed, S. Murphy, and M.V. Jayson Measurement of psychiatric disorder in rheumatoid arthritis Journal of Psychosom Research 34 1990 79 87 (Pubitemid 20097739)
42. D.J. Hawley, and F. Wolfe Anxiety and depression in patients with rheumatoid arthritis: a prospective study of 400 patients Journal of Rheumatology 15 1988 932 941
43. P.P. Katz, and E.H. Yelin Prevalence and correlates of depressive symptoms among persons with rheumatoid arthritis Journal of Rheumatology 20 1993 790 796 (Pubitemid 23158471)
44. D.L. Scott, and V. Strand The effects of disease-modifying anti-rheumatic drugs on the Health Assessment Questionnaire score. Lessons from the leflunomide clinical trials database Rheumatology 41 2002 899 909
45. D.L. Scott, C. Smith, and G. Kingsley Joint damage and disability in rheumatoid arthritis: an updated systematic review Clinical and Experimental Rheumatology 21 Suppl 31 2003 S20 S27 (Pubitemid 37265584)
46. M. Margaretten, E. Yelin, J. Imboden, J. Graf, J. Barton, and P. Katz Predictors of depression in a multiethnic cohort of patients with rheumatoid arthritis Arthritis Rheumatism 61 2009 1586 1591
47. M. Margaretten, J. Barton, L. Julian, P. Katz, L. Trupin, and C. Tonner Socioeconomic determinants of disability and depression in patients with rheumatoid arthritis Arthritis Care Research 63 2011 240 246
48. H. Radner, J.S. Smolen, and D. Aletaha Comorbidity affects all domains of physical function and quality of life in patients with rheumatoid arthritis Rheumatology 50 2011 381 388
49. M. Ahlmén, B. Svensson, K. Albertsson, K. Forslind, and I. Hafström BARFOT Study Group. Influence of gender on assessments of disease activity and function in early rheumatoid arthritis in relation to radiographic joint damage Annals of the Rheumatic Diseases 69 2010 230 233
50. P.M. Welsing, J. Fransen, and P.L. van Riel Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis Arthritis Rheumatism 52 2005 2616 2624 (Pubitemid 41369089)
51. K.W. Drossaers-Bakker, M. de Buck, D. van Zeben, A.H. Zwinderman, F.C. Breedveld, and J.M. Hazes Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time Arthritis Rheumatism 42 1999 1854 1860 (Pubitemid 30257749)
52. F. Wolfe A reappraisal of HAQ disability in rheumatoid arthritis Arthritis Rheumatism 43 2000 2751 2761 (Pubitemid 32001741)
53. V. Strand, P. Mease, G.R. Burmester, E. Nikaï, G. Coteur, and R. van Vollenhoven Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year:results from the RAPID 1 randomized controlled trial Arthritis Research Therapy 11 2009 R170
54. K.L. Hyrich, C. Deighton, and K.D. Watson BSRBR control centre Consortium, Symmons DP, Lunt M; British society for rheumatology biologics register. Benefit of anti-TNF therapy in rheumatoid arthritis patients with moderate disease activity Rheumatology 48 2009 1323 1327
55. D. Aletaha, and M.M. Ward Duration of rheumatoid arthritis influences the degree of functional improvement in clinical trials Annals of the Rheumatic Diseases 65 2006 227 233 (Pubitemid 43131998)
56. D. Aletaha, V. Strand, J.S. Smolen, and M.M. Ward Treatment-related improvement in physical function varies with duration of rheumatoid arthritis: a pooled analysis of clinical trial results Annals of the Rheumatic Diseases 67 2008 238 243 (Pubitemid 351183315)
57. D.L. Scott, K. Pugner, K. Kaarela, D.V. Doyle, A. Woolf, and J. Holmes The links between joint damage and disability in rheumatoid arthritis Rheumatology 39 2000 122 132 (Pubitemid 30139344)
58. N. Wiles, G. Dunn, E. Barrett, A. Silman, and D. Symmons Associations between demographic and disease-related variables and disability over the first five years of inflammatory polyarthritis: a longitudinal analysis using generalized estimating equations Journal of Clinical Epidemiology 53 2000 988 996
59. P. Gordon, J. West, H. Jones, and T.A. Gibson 10 year prospective followup of patients with rheumatoid arthritis 1986-96 Journal of Rheumatology 28 2001 2409 2415 (Pubitemid 33031969)
60. P.M. Welsing, A.M. van Gestel, H.L. Swinkels, L.A. Kiemeney, and P.L. van Riel The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis Arthritis Rheumatism 44 2001 2009 2017 (Pubitemid 33644042)
61. E. Lindqvist, T. Saxne, P. Geborek, and K. Eberhardt Ten year outcome in a cohort of patients with early rheumatoid arthritis: health status, disease process, and damage Annals of the Rheumatic Diseases 61 2002 1055 1059 (Pubitemid 35397350)
62. M.J. Plant, M.M. O'Sullivan, P.A. Lewis, J.P. Camilleri, E.C. Coles, and J.D. Jessop What factors influence functional ability in patients with rheumatoid arthritis. Do they alter over time? Rheumatology 44 2005 1181 1185 (Pubitemid 41236028)
63. I. Rupp, H.C. Boshuizen, H.J. Dinant, C.E. Jacobi, and G.A. van den Bos Disability and health-related quality of life among patients with rheumatoid arthritis: association with radiographic joint damage, disease activity, pain, and depressive symptoms Scandinavian Journal of Rheumatology 35 2006 175 181 (Pubitemid 43890736)
64. T. Sokka, H. Kautiainen, P. Hannonen, and T. Pincus Changes in health assessment questionnaire disability scores over five years in patients with rheumatoid arthritis compared with the general population Arthritis Rheumatism 54 2006 3113 3118 (Pubitemid 44622080)
65. D. Symmons, K. Tricker, M. Harrison, C. Roberts, M. Davis, and P. Dawes British Rheumatoid Outcome Study Group. Patients with stable long-standing rheumatoid arthritis continue to deteriorate despite intensified treatment with traditional disease modifying anti-rheumatic drugs-results of the British Rheumatoid Outcome Study Group randomized controlled clinical trial Rheumatology 45 2006 558 565
66. E. Tanaka, A. Mannalithara, E. Inoue, M. Hara, T. Tomatsu, and N. Kamatani Efficient management of rheumatoid arthritis significantly reduces long-term functional disability Annals of the Rheumatic Diseases 67 2008 1153 1158
67. N. Courvoisier, M. Dougados, A. Cantagrel, P. Goupille, O. Meyer, and J. Sibilia Prognostic factors of 10-year radiographic outcome in early rheumatoid arthritis: a prospective study Arthritis Research Therapy 10 2008 R106
68. J.E. Pope, D. Khanna, D. Norrie, and J.M. Ouimet The minimally important difference for the health assessment questionnaire in rheumatoid arthritis clinical practice is smaller than in randomized controlled trials Journal of Rheumatology 36 2009 254 259
69. F. Wolfe, and K. Michaud The loss of health status in rheumatoid arthritis and the effect of biologic therapy: a longitudinal observational study Arthritis Research Therapy 12 2 2010 R35
70. N.P. Hurst, P. Kind, D. Ruta, M. Hunter, and A. Stubbings Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D) British Journal of Rheumatology 36 1997 551 559
71. M.J. Harrison, L.M. Davies, N.J. Bansback, M. Ingram, A.H. Anis, and D.P. Symmons The validity and responsiveness of generic utility measures in rheumatoid arthritis: a review Journal of Rheumatology 35 2008 592 602 (Pubitemid 351500053)
72. F. Wolfe, and D.J. Hawley Measurement of the quality of life in rheumatic disorders using the EuroQol British Journal of Rheumatology 36 1997 786 793
73. D.L. Scott, B. Khoshaba, E.H. Choy, and G.H. Kingsley Limited correlation between the Health Assessment Questionnaire (HAQ) and EuroQol in rheumatoid arthritis: questionable validity of deriving quality adjusted life years from HAQ Annals of the Rheumatic Diseases 66 2007 1534 1537 (Pubitemid 350032666)
74. M.J. Harrison, L.M. Davies, N.J. Bansback, M.J. McCoy, T.M. Farragher, and S.M. Verstappen Why do patients with inflammatory arthritis often score states "worse than death" on the EQ-5D? An Investigation of the EQ-5D classification system Value Health 12 2009 1026 1034
75. M.J. Harrison, K.J. Tricker, L. Davies, A. Hassell, P. Dawes, and D.L. Scott The relationship between social deprivation, disease outcome measures, and response to treatment in patients with stable, long-standing rheumatoid arthritis Journal of Rheumatology 32 2005 2330 2336 (Pubitemid 41782233)
76. F. Wolfe, K. Michaud, T. Li, and R.S. Katz Chronic conditions and health problems in rheumatic diseases: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, systemic lupus erythematosus, and fibromyalgia Journal of Rheumatology 37 2010 305 315
77. D. Symmons, K. Tricker, C. Roberts, L. Davies, P. Dawes, and D.L. Scott The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis Health Technology Assessment 9 2005 1 78
78. A. Gülfe, L.E. Kristensen, T. Saxne, L.T. Jacobsson, I.F. Petersson, and P. Geborek Utility-based outcomes made easy: the number needed per quality-adjusted life year gained. An observational cohort study of tumor necrosis factor blockade in inflammatory arthritis from Southern Sweden Arthritis Care Research 62 2010 1399 1406
79. L. Gossec, M. Dougados, N. Rincheval, A. Balanescu, D.T. Boumpas, and S. Canadelo Elaboration of the preliminary rheumatoid arthritis impact of disease (RAID) score: a EULAR initiative Annals of the Rheumatic Diseases 68 2009 1680 1685
80. T. Heiberg, C. Austad, T.K. Kvien, and T. Uhlig Performance of the Rheumatoid Arthritis Impact of Disease (RAID) score in relation to other patient-reported outcomes in a register of patients with rheumatoid arthritis Annals of the Rheumatic Diseases 70 2011 1080 1082
81. N.J. Gullick, and D.L. Scott Rheumatoid arthritis: clinical utility of the RAID (RA impact of disease) score Nature Reviews Rheumatology 7 2011 499 500
82. A. Boonen, and J.L. Severens The burden of illness of rheumatoid arthritis Clinical Rheumatology 30 Suppl. 1 2011 Mar S3 S8
83. A.G. Witney, G.J. Treharne, M. Tavakoli, A.C. Lyons, K. Vincent, and D.L. Scott The relationship of medical, demographic and psychosocial factors to direct and indirect health utility instruments in rheumatoid arthritis Rheumatology 45 2006 975 981 (Pubitemid 44283052)
84. S. Lillegraven, I.S. Kristiansen, and T.K. Kvien Comparison of utility measures and their relationship with other health status measures in 1041 patients with rheumatoid arthritis Annals of the Rheumatic Diseases 69 2010 1762 1767
85. C.A. Marra, N. Bansback, A.H. Anis, and K. Shojania Introduction to economic modelling for clinical rheumatologists: application to biologic agents in rheumatoid arthritis Clinical Rheumatology 30 Suppl 1 2011 S9 18
86. M.J. Harrison, M. Lunt, S.M. Verstappen, K.D. Watson, N.J. Bansback, and D.P. Symmons Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis Health Quality Life of Outcomes 8 2010 21
87. M. Schoels, J. Wong, D.L. Scott, A. Zink, P. Richards, and R. Landewé Economic aspects of treatment options in rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis Annals of the Rheumatic Diseases 69 2010 995 1003
88. A. Brennan, N. Bansback, R. Nixon, J. Madan, M. Harrison, and K. Watson Modelling the cost effectiveness of TNF-alpha antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry Rheumatology 46 2007 1345 1354 (Pubitemid 47244512)
89. G. van der Velde, B. Pham, M. Machado, L. Ieraci, W. Witteman, and C. Bombardier Cost-effectiveness of biologic response modifiers compared to disease-modifying antirheumatic drugs for rheumatoid arthritis: a systematic review Arthritis Care Research 63 2011 65 78
90. Y.F. Chen, P. Jobanputra, P. Barton, S. Jowett, S. Bryan, and W. Clark A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness Health Technology Assessesment 10 2006 1 229
91. J.T. Giles, S.J. Bartlett, A.C. Gelber, S. Nanda, K. Fontaine, and V. Ruffing Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis Arthritis Rheumatism 55 2006 333 337
92. J.B. Galloway, K.L. Hyrich, L.K. Mercer, W.G. Dixon, A.P. Ustianowski, and M. Helbert on behalf of the BSR Biologics Register. Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register Annals of the Rheumatic Diseases 70 2011 1810 1814
93. K. Hekmat, L. Jacobsson, J.A. Nilsson, I.F. Petersson, O. Robertsson, and G. Garellick Decrease in the incidence of total hip arthroplasties in patients with rheumatoid arthritis - results from a well defined population in south Sweden Arthritis Research Therapy 13 2011 R67
94. I.J. Higginson, and A.J. Carr Measuring quality of life: using quality of life measures in the clinical setting British Medical Journal 322 2001 1297 1300 (Pubitemid 32493968)
95. L. Pollard, E.H. Choy, and D.L. Scott The consequences of rheumatoid arthritis: quality of life measures in the individual patient Clinical and Experimental Rheumatology 23 5 Suppl. 39 2005 S43 S52 (Pubitemid 46657510)